Ready-to-Use Therapeutic Food
APAC · 1 shared keyword
APAC Mosquito Control Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Buyer, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
APAC · 2024–2034 · estimates
Market Dashboard
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Estimate 2024
$1.25 Bn
Estimated value
Estimate 2025
$1.32 Bn
20% of the global market
Projected 2034
$2.22 Bn 67.5%
Adds $893.1 Mn over 9 forecast years
CAGR 2025–2034
5.9%
Faster than 7% of 82 OTC & Nutraceuticals markets here
Key players
5
- APAC is 20% of the global market.
- Among regions, the largest is North America at $3.50 Bn.
- Fastest growing: Africa at 6.9% a year.
- APAC ranks 2nd of 6 by size among regions.
Market size projection
APACSource: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
Value added each year
$893.1 Mn total, 2026–2034
Year-by-year market size, 2024–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.25 Bn | — | — |
| 2025 (base) | $1.32 Bn | +$73.7 Mn | — |
| 2026 (forecast) | $1.40 Bn | +$78.0 Mn | +5.9% |
| 2027 (forecast) | $1.48 Bn | +$82.6 Mn | +12.1% |
| 2028 (forecast) | $1.57 Bn | +$87.5 Mn | +18.8% |
| 2029 (forecast) | $1.66 Bn | +$92.7 Mn | +25.8% |
| 2030 (forecast) | $1.76 Bn | +$98.2 Mn | +33.2% |
| 2031 (forecast) | $1.87 Bn | +$103.9 Mn | +41.1% |
| 2032 (forecast) | $1.98 Bn | +$110.1 Mn | +49.4% |
| 2033 (forecast) | $2.09 Bn | +$116.6 Mn | +58.2% |
| 2034 (forecast) | $2.22 Bn | +$123.5 Mn | +67.5% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
Same market worldwide
By geography
- Global $6.62 Bn
- North America $3.50 Bn
-
US
$2.91 Bn
- APAC (this report) $1.32 Bn
- Europe $1.13 Bn
-
Canada
$543.4 Mn
-
China
$507.4 Mn
-
Japan
$468.1 Mn
- Latin America $329.5 Mn
- Middle East $280.3 Mn
-
Germany
$217.0 Mn
-
UK
$189.2 Mn
-
France
$162.7 Mn
-
Brazil
$164.2 Mn
-
Spain
$139.2 Mn
-
Italy
$140.0 Mn
-
Ecuador
$131.3 Mn
-
Saudi Arabia
$125.9 Mn
-
India
$123.5 Mn
- Africa $103.0 Mn
-
Mexico
$92.0 Mn
-
Australia
$79.4 Mn
-
Russia
$68.4 Mn
-
New Zealand
$64.1 Mn
-
South Africa
$42.6 Mn
-
UAE
$35.1 Mn
-
Egypt
$19.6 Mn
-
Philippines
$13.7 Mn
-
Malaysia
$9.7 Mn
-
Hong Kong
$9.3 Mn
-
Singapore
$8.8 Mn
-
Thailand
$7.5 Mn
-
Kenya
$4.8 Mn
The APAC Mosquito Control Products Market Analysis Executive Summary
Mosquito control products prevent malaria, dengue and other mosquito-borne diseases, including bed nets, sprays and repellents.
Key segments of the mosquito Control Products market include product (Insecticide-Treated Nets, Indoor Residual Spraying and Repellents) and buyer (Governments, Global Funds and Households).
APAC Mosquito Control Products Market Dynamics
Market Growth Drivers
Global health goals, donor and government funding, better mobile technology and focus on preventing disease are driving the mosquito Control Products market.
Opportunity
Digital tools for community health, local manufacturing and public-private partnerships give the mosquito Control Products market room to grow.
Market Restraints
Limited budgets, weak health systems in some regions, workforce shortages and supply chain gaps hold back the mosquito Control Products market.
Competitive Landscape for Mosquito Control Products Market in APAC
The mosquito Control Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Key Players
Healthcare Policies and Regulatory Landscape for Mosquito Control Products Market in APAC
Mosquito Control Products in APAC: rules
In some of the countries we cover here, medicines are approved by TGA (Australia)[1], NMPA (China)[2], Drug Office (Hong Kong)[3], CDSCO (India)[4], PMDA (Japan)[5], NPRA (Malaysia)[6], Medsafe (New Zealand)[7], FDA Philippines (Philippines)[8], HSA (Singapore)[9] and Thai FDA (Thailand)[10]. In some of the countries we cover here, supplement rules come from TGA (Australia)[1], SAMR (China)[11], Centre for Food Safety (Hong Kong)[12], FSSAI (India)[13], Consumer Affairs Agency (Japan)[14], NPRA (Malaysia)[6], MPI (New Zealand)[15], FDA Philippines (Philippines)[8], HSA (Singapore)[9] and Thai FDA (Thailand)[10].
[1] Therapeutic Goods Administration. Checked 14 Nov 2026.
[2] National Medical Products Administration. Checked 14 Nov 2026.
[3] Drug Office, Department of Health. Checked 14 Nov 2026.
[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.
[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
[6] National Pharmaceutical Regulatory Agency. Checked 14 Nov 2026.
[7] Medsafe. Checked 14 Nov 2026.
[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.
[9] Health Sciences Authority. Checked 14 Nov 2026.
[10] Thai Food and Drug Administration. Checked 14 Nov 2026.
[11] State Administration for Market Regulation. Checked 14 Nov 2026.
[12] Centre for Food Safety. Checked 14 Nov 2026.
[13] Food Safety and Standards Authority of India. Checked 14 Nov 2026.
[14] Consumer Affairs Agency. Checked 14 Nov 2026.
[15] Ministry for Primary Industries. Checked 14 Nov 2026.
Policy changes and Reimbursement scenario
Food and supplement rules, labelling and health-claim regulations govern mosquito Control Products products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in APAC.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Mosquito Control Products right now, from free public sources.
Latest research 19 papers since 2021 (worldwide)
- Do mosquito insecticides harm beneficial mosquitoes? Evidence from Toxorhynchites rutilus septentrionalis (Diptera: Culicidae). Journal of medical entomology, 2026
- Knowledge, attitudes, and practices related to spatial repellent for mosquito control and malaria risk perception in East Sumba, Indonesia. PLOS global public health, 2026
- High resistance of Anopheles gambiae s.L. populations to public health insecticides in Ghana: contribution of domestic and agricultural pesticide use. BMC infectious diseases, 2026
- Mosquito larvicide and adulticide impacts on adult western honey bees (Apis mellifera) in in vitro cage studies. Environmental science and pollution research international, 2026
- A retail audit of mosquito control products in Bidibidi refugee settlement, northwestern Uganda. Malaria journal, 2025
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
Mosquito Control Products in context
Questions, answered with public data
- How much research is published on Mosquito Control Products?
- PubMed lists 19 papers added since January 2021 that match this market, worldwide.[1]
[1] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Free data on this topic
From our blog
Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
Antimicrobial Resistance: Why Faster Testing MattersDrug-resistant infections already kill over a million people a year. Faster testing helps doctors pick the…
Needleless Connectors: Small Device, Big Infection ImpactNeedleless connectors protect staff from needle injuries, but if not cleaned they can let germs into the…